Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin

M Adjobimey1, E Masserey2, C Adjonou1

  • 1Centre National Hospitalier de Pneumo-Phtisiologie, Cotonou, Benin.

Insights

Integrating isoniazid preventive therapy (IPT) for young children exposed to tuberculosis (TB) into national programs in Benin was feasible. High adherence rates were observed, demonstrating the effectiveness of this public health intervention.

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Pediatric Infectious Diseases

Background:

  • Tuberculosis (TB) remains a significant global health challenge, particularly affecting vulnerable populations like young children.
  • Preventive therapy is crucial for reducing TB transmission and disease burden in exposed individuals.
  • Integrating preventive strategies into existing national health programs enhances their reach and sustainability.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of incorporating isoniazid preventive therapy (IPT) for children under 5 years old into Benin's National TB Programme (NTP).
  • To assess the adherence and clinical results of IPT in a real-world, program setting.

Main Methods:

  • The study involved children under 5 years old who were household contacts of smear-positive pulmonary TB patients in Benin.
  • Children received a medical examination and IPT if no active TB was detected, followed by clinical monitoring for 6 months.
  • Data were collected from January 2013 to June 2014.

Main Results:

  • Out of 499 notified contacts, 496 children were examined and prescribed IPT.
  • An 86% adherence rate to IPT for at least 6 months was achieved.
  • Six deaths and three cases of active TB occurred, primarily within the first 3 months of follow-up.

Conclusions:

  • Integrating IPT for child contacts into a well-functioning National TB Programme in a moderate TB incidence African country is feasible.
  • Simple tools and integration with existing index case management facilitated the program.
  • High adherence rates suggest the effectiveness and practicality of this approach for childhood TB prevention.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
737
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
617
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360